High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation

Anja Wiedswang Horjen1, Sara Reinvik Ulimoen, Ingebjørg Seljeflot

  • 1Department of Medical Research, Vestre Viken Hospital Trust, Bx00E6;rum Hospital, Drammen, Norway.

Cardiology
|December 25, 2015
PubMed

Insights

High-sensitivity troponin I (hs-TnI) did not predict atrial fibrillation (AF) recurrence after cardioversion. hs-TnI levels remained stable in patients maintaining sinus rhythm and were unaffected by candesartan treatment.

Area of Science:

  • Cardiology
  • Biomarkers
  • Electrophysiology

Background:

  • Persistent atrial fibrillation (AF) poses a significant clinical challenge.
  • Cardioversion is a common procedure to restore sinus rhythm.
  • Predictors of long-term rhythm outcome after cardioversion are crucial for patient management.

Purpose of the Study:

  • To investigate if high-sensitivity troponin I (hs-TnI) predicts long-term rhythm outcome after cardioversion for persistent AF.
  • To determine if maintaining sinus rhythm or candesartan treatment reduces hs-TnI levels.

Main Methods:

  • A double-blind, placebo-controlled study involving 171 patients undergoing electrical cardioversion for AF.
  • Patients were randomized to receive candesartan or placebo.
  • hs-TnI levels were measured at baseline and study end in successfully cardioverted patients.

Main Results:

  • hs-TnI was detectable in all subjects, with a median baseline of 5.3 ng/l.
  • Baseline hs-TnI did not predict rhythm outcome 6 months post-cardioversion.
  • Candesartan treatment did not affect hs-TnI levels, nor did maintaining sinus rhythm.

Conclusions:

  • hs-TnI is not a predictor of AF recurrence after cardioversion.
  • Maintaining sinus rhythm for 6 months does not alter hs-TnI levels.
  • Candesartan does not influence hs-TnI levels in this context.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
947
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.6K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
613
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
10.3K
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K